Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Candidemia D058387 2 associated lipids
Blastomycosis D001759 5 associated lipids
Aspergillosis D001228 5 associated lipids
Vaginitis D014627 6 associated lipids
Xerostomia D014987 6 associated lipids
Gonorrhea D006069 7 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Otitis Externa D010032 8 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Urethritis D014526 9 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Influenza, Human D007251 11 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
HIV Seropositivity D006679 15 associated lipids
Dermatomycoses D003881 17 associated lipids
Mycoses D009181 18 associated lipids
Leishmaniasis D007896 19 associated lipids
Burns D002056 34 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Yin X et al. Differential signaling pathways in angiotensin II- and epidermal growth factor-stimulated hepatic C9 cells. 2008 Mol. Pharmacol. pmid:18687808
McFarland MJ et al. RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells. 2008 Mol. Pharmacol. pmid:18436710
Farran L et al. Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgery. 2008 Dis. Esophagus pmid:18269652
Masood A et al. A randomised controlled trial comparing Triadcortyl with 10% glycerine-ichthammol in the initial treatment of severe acute otitis externa. 2008 Eur Arch Otorhinolaryngol pmid:17922130
Livraghi A et al. Modelling dysregulated Na+ absorption in airway epithelial cells with mucosal nystatin treatment. 2008 Am. J. Respir. Cell Mol. Biol. pmid:17989361
Ohnemus U et al. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents. 2008 Mycoses pmid:18076591
Gallegos CE et al. Ceramides modulate cell-surface acetylcholine receptor levels. 2008 Biochim. Biophys. Acta pmid:18023270
Shankarnarayan S et al. Modulation of yeast Sln1 kinase activity by the CCW12 cell wall protein. 2008 J. Biol. Chem. pmid:18048366
te Welscher YM et al. Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane. 2008 J. Biol. Chem. pmid:18165687
Egido W et al. Maitotoxin induces two dose-dependent conductances in Xenopus oocytes. Comparison with nystatin effects as a pore inductor. 2008 Toxicon pmid:18255116
Iwaki T et al. Multiple functions of ergosterol in the fission yeast Schizosaccharomyces pombe. 2008 Microbiology (Reading, Engl.) pmid:18310029
Oliver BG et al. Polyene susceptibility is dependent on nitrogen source in the opportunistic pathogen Candida albicans. 2008 J. Antimicrob. Chemother. pmid:18343803
Lamberti Y et al. Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils. 2008 Microb. Pathog. pmid:18276103
Shlyonsky V et al. Electrophysiological characterization of rat type II pneumocytes in situ. 2008 Am. J. Respir. Cell Mol. Biol. pmid:18276797
Shin MC et al. A selective T-type Ca2+ channel blocker R(-) efonidipine. 2008 Naunyn Schmiedebergs Arch. Pharmacol. pmid:18278483
Catalán A et al. In vitro and in vivo activity of Melaleuca alternifolia mixed with tissue conditioner on Candida albicans. 2008 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:18280967
Maza PK et al. Interaction of epithelial cell membrane rafts with Paracoccidioides brasiliensis leads to fungal adhesion and Src-family kinase activation. 2008 Microbes Infect. pmid:18403242
Jackson SK et al. Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response. 2008 J. Leukoc. Biol. pmid:18403647
O'Grady MJ and Dempsey EM Antifungal prophylaxis for the prevention of neonatal candidiasis? 2008 Acta Paediatr. pmid:18363952
Lee JJ et al. 5-HT1A receptor-mediated activation of a G-protein-coupled inwardly rectifying K+ current in rat medial preoptic area neurons. 2008 Eur. J. Pharmacol. pmid:18367171
Placzek EA et al. Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. 2008 J. Neurochem. pmid:18778304
Lye WC Nystatin prophylaxis for fungal peritonitis: to be or not to be? 2007 Sep-Oct Perit Dial Int pmid:17704437
Wong PN et al. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. 2007 Sep-Oct Perit Dial Int pmid:17704443
Tallury P et al. Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer. 2007 Dent Mater pmid:17049593
Llabot JM et al. Design of novel antifungal mucoadhesive films Part I. Pre-formulation studies. 2007 Int J Pharm pmid:17071026
Nakhla V et al. Myringoplasty: a comparison of bismuth iodoform paraffin paste gauze pack and tri-adcortyl ointment ear dressing. 2007 J Laryngol Otol pmid:17105678
Tobey NA et al. Effect of luminal acidity on the apical cation channel in rabbit esophageal epithelium. 2007 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:16614374
Liu YT et al. Heparin suppresses lipid raft-mediated signaling and ligand-independent EGF receptor activation. 2007 J. Cell. Physiol. pmid:17226785
Zheng T et al. Prostaglandin E2 has no effect on two components of tetrodotoxin-resistant Na+ current in mouse dorsal root ganglion. 2007 J. Pharmacol. Sci. pmid:17220592
Llabot JM et al. Design of novel antifungal mucoadhesive films. Part II. Formulation and in vitro biopharmaceutical evaluation. 2007 Int J Pharm pmid:17223291
Nedal A et al. Analysis of the mycosamine biosynthesis and attachment genes in the nystatin biosynthetic gene cluster of Streptomyces noursei ATCC 11455. 2007 Appl. Environ. Microbiol. pmid:17905880
Hac-Wydro K et al. The influence of phospholipid structure on the interactions with nystatin, a polyene antifungal antibiotic A Langmuir monolayer study. 2007 Chem. Phys. Lipids pmid:17681287
Randhawa P et al. BK Virus replication in vitro: limited effect of drugs interfering with viral uptake and intracellular transport. 2007 Antimicrob. Agents Chemother. pmid:17893158
Mole R et al. Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis. 2007 J. Med. Microbiol. pmid:17893170
Albert H et al. Development of an antimicrobial formulation for control of specimen-related contamination in phage-based diagnostic testing for tuberculosis. 2007 J. Appl. Microbiol. pmid:17897191
des Rieux A et al. An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. 2007 Eur J Pharm Sci pmid:17291730
Anderson O and Takwoingi YM Tri-adcortyl ointment ear dressing in myringoplasty: an analysis of outcome. 2007 Eur Arch Otorhinolaryngol pmid:17361408
Moriyama T et al. Caveolar endocytosis is critical for BK virus infection of human renal proximal tubular epithelial cells. 2007 J. Virol. pmid:17553887
Kuete V et al. Antimicrobial activity of the methanolic extracts and compounds from Treculia obovoidea (Moraceae). 2007 J Ethnopharmacol pmid:17532157
Katsu T et al. Simultaneous measurements of K+ and calcein release from liposomes and the determination of pore size formed in a membrane. 2007 Anal Sci pmid:17495394
Ma X et al. Lateral diffusion of TGF-beta type I receptor studied by single-molecule imaging. 2007 Biochem. Biophys. Res. Commun. pmid:17346672
Martínez FV et al. Delayed hypersensitivity to oral nystatin. 2007 Contact Derm. pmid:17680880
Llabot JM et al. HPLC method for the determination of nystatin in saliva for application in clinical studies. 2007 J Pharm Biomed Anal pmid:17658236
Pacheco M et al. Attachment and entry of Candida famata in monocytes and epithelial cells. 2007 Microsc. Res. Tech. pmid:17661391
Serfling A et al. Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy. 2007 Antimicrob. Agents Chemother. pmid:17620378
Lewith GT et al. Elevation of Candida IgG antibodies in patients with medically unexplained symptoms. 2007 J Altern Complement Med pmid:18166126
Banfi C et al. Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells. 2007 J. Thromb. Haemost. pmid:17848177
Hernandez-Machin B et al. Picture of the month: diagnosis. 2007 Arch Pediatr Adolesc Med pmid:17768292
Martín-Acebes MA et al. Productive entry of type C foot-and-mouth disease virus into susceptible cultured cells requires clathrin and is dependent on the presence of plasma membrane cholesterol. 2007 Virology pmid:17714753
Khan A et al. A new triterpenoid from roots of Laportea crenulata and its antifungal activity. 2007 Nat. Prod. Res. pmid:17691044